KE, C., SH, H., RA, C., DL, W., AM, B., AS, F., . . . KJ, T. (2025). Discovery of Thieno[3,2-b]pyridine-5-carboxamide and 2,3-Difluorobenzamide Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5. ACS medicinal chemistry letters, 16(5), 865. https://doi.org/10.1021/acsmedchemlett.5c00119
Chicago Style (17th ed.) CitationKE, Crocker, et al. "Discovery of Thieno[3,2-b]pyridine-5-carboxamide and 2,3-Difluorobenzamide Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5." ACS Medicinal Chemistry Letters 16, no. 5 (2025): 865. https://doi.org/10.1021/acsmedchemlett.5c00119.
MLA (9th ed.) CitationKE, Crocker, et al. "Discovery of Thieno[3,2-b]pyridine-5-carboxamide and 2,3-Difluorobenzamide Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5." ACS Medicinal Chemistry Letters, vol. 16, no. 5, 2025, p. 865, https://doi.org/10.1021/acsmedchemlett.5c00119.